Highly enantioselective and efficient synthesis of methyl (R)-o-chloromandelate with recombinant E. coli: toward practical and green access to clopidogrel.
Highly enantioselective and efficient synthesis of methyl (R)-o-chloromandelate with recombinant E. coli: toward practical and green access to clopidogrel.
复制标题
DOI:
10.1039/b703463f
复制
发表时间:
2007-04
影响因子:
3.2
通讯作者:
T. Ema;Nobuyasu Okita;Sayaka Ide;T. Sakai
中科院分区:
文献类型:
--
作者:
T. Ema;Nobuyasu Okita;Sayaka Ide;T. Sakai
Methyl (R)-o-chloromandelate ((R)-), which is an intermediate for a platelet aggregation inhibitor named clopidogrel, was obtained in >99% ee by the asymmetric reduction of methyl o-chlorobenzoylformate (2) (up to 1.0 M) with recombinant E. coli overproducing a versatile carbonyl reductase.